E
LSL Pharma Group Inc. LSL.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Total Cash And Short-Term Investments -- -45.55% -- -- --
Total Receivables 93.54% 116.47% -- 164.53% -12.98%
Inventory 45.59% 16.54% -- 42.41% 12.49%
Prepaid Expenses 71.02% 149.16% -- 100.59% 38.51%
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets 63.99% 41.06% -- 67.99% 3.40%

Total Current Assets 63.99% 41.06% -- 67.99% 3.40%
Net Property, Plant & Equipment 27.34% 24.55% -- 8.59% 8.09%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles 4.90% -0.22% -- 1.91% -2.55%
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 0.00% -3.31% -- 2.03% 1.37%
Total Assets 28.17% 20.94% -- 15.95% 3.80%

Total Accounts Payable -14.41% -37.66% -- 11.09% -39.06%
Total Accrued Expenses -- -- -- -31.38% --
Short-term Debt -60.64% 55.86% -- 32.54% 172.28%
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -35.68% 160.15% -- 218.62% 297.17%
Total Finance Division Other Current Liabilities -- -- -- -- 60.50%
Total Other Current Liabilities -- -- -- -- 60.50%
Total Current Liabilities -40.47% -13.91% -- 32.97% 40.23%

Total Current Liabilities -40.47% -13.91% -- 32.97% 40.23%
Long-Term Debt 104.14% -7.82% -- -38.15% -56.46%
Short-term Debt -60.64% 55.86% -- 32.54% 172.28%
Capital Leases 4.26% -8.64% -- -2.44% -3.44%
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities -11.51% -11.06% -- 3.53% -0.75%

Common Stock & APIC 43.45% 33.94% -- 80.51% 81.44%
Retained Earnings -9.48% -8.33% -- -91.42% -167.20%
Treasury Stock & Other -- -- -- -- --
Total Common Equity 109.16% 78.66% 176.94% 67.64% 14.51%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 109.16% 78.66% 176.94% 67.64% 14.51%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 109.16% 78.66% 176.94% 67.64% 14.51%

Weiss Ratings